A review of combination adjuvants for malaria vaccines: a promising approach for vaccine development
S Pirahmadi, S Zakeri, ND Djadid, AA Mehrizi - International journal for …, 2021 - Elsevier
… approach in subunit malaria vaccine development, this … known combination adjuvants used
in malaria subunit vaccines, … these combination adjuvants in experimental malaria vaccines. …
in malaria subunit vaccines, … these combination adjuvants in experimental malaria vaccines. …
Improved antitumor efficacy of combined vaccine based on the induced HUVECs and DC-CT26 against colorectal carcinoma
Q Zhang, C Xie, D Wang, Y Yang, H Liu, K Liu, J Zhao… - Cells, 2019 - mdpi.com
… In conclusion, this study demonstrates that the combined vaccine containing induced HUVECs
with DC-CT26 elicits strong humoral and cellular immune responses targeting both tumor …
with DC-CT26 elicits strong humoral and cellular immune responses targeting both tumor …
[HTML][HTML] DNA vaccines: prime time is now
EN Gary, DB Weiner - Current Opinion in Immunology, 2020 - Elsevier
Recently newer synthetic DNA vaccines have been rapidly … electroporation (EP), combined
with other advances, induces … recent studies of synthetic DNA vaccines in the clinic for the …
with other advances, induces … recent studies of synthetic DNA vaccines in the clinic for the …
[HTML][HTML] A D-peptide-based HIV gelatinous combination vaccine improves therapy in ART-delayed macaques of chronic infection
Y Liu, X Ji, Y Liu, D Li, Y Cun, Y Zhang, R Wang, Y Hao… - Nano Today, 2022 - Elsevier
… combination vaccine strategies. We hypothesize that an advanced function-combined vaccine
… In the current study, we constructed a D-peptidic gelatinous combination vaccine (GCV) …
… In the current study, we constructed a D-peptidic gelatinous combination vaccine (GCV) …
… of Mycoplasma hyopneumoniae and porcine circovirus 2 commercial vaccines efficacy when applied separate or combined under experimental conditions
M Sibila, G Guevara, R Cuadrado… - Porcine health …, 2020 - Springer
… ), and that vaccine application is usually in the piglet, the concept of combined vaccination
has been explored in the last 10 years. Such combined applications imply less handling …
has been explored in the last 10 years. Such combined applications imply less handling …
Towards a mechanistic understanding of the synergistic response induced by bivalent Marek's disease vaccines to prevent lymphomas
… has been controlled by widespread vaccination; however, more effective MD vaccines are
needed to counter more virulent MDV strains. The bivalent vaccine combination of SB-1 and …
needed to counter more virulent MDV strains. The bivalent vaccine combination of SB-1 and …
[HTML][HTML] The role of vaccines in combatting antimicrobial resistance
F Micoli, F Bagnoli, R Rappuoli, D Serruto - Nature Reviews …, 2021 - nature.com
… Also, considering that the greatest burden of disease is in LMICs, development of combination
vaccines, covering other enteric diseases such as enterotoxigenic E. coli infection, should …
vaccines, covering other enteric diseases such as enterotoxigenic E. coli infection, should …
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
J Galon, D Bruni - Nature reviews Drug discovery, 2019 - nature.com
… combination immunotherapies, including checkpoint inhibitors. In the upcoming era of
combination … The impact of combination therapy on the immune response to convert an immune …
combination … The impact of combination therapy on the immune response to convert an immune …
Adjuvants for coronavirus vaccines
Z Liang, H Zhu, X Wang, B Jing, Z Li, X Xia… - Frontiers in …, 2020 - frontiersin.org
… a foundation for the combination of CpG with other adjuvants, most commonly alum (65). In
SARS-CoV or MERS-CoV subunit vaccines, studies have found that the combination of alum …
SARS-CoV or MERS-CoV subunit vaccines, studies have found that the combination of alum …
Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised …
… to date no vaccines against genital chlamydia have been tested in clinical trials. We aimed
to assess the safety and immunogenicity, in humans, of a novel chlamydia vaccine based on …
to assess the safety and immunogenicity, in humans, of a novel chlamydia vaccine based on …